MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$22,491,000
EPS
-$0.28
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
-
-
0*
-
Research and development
16,172,000
13,397,977
7,442,302*
8,970,010
General and administrative
7,205,000
6,599,759
3,474,154*
3,708,959
Total operating expenses
23,377,000
19,997,736
10,916,456*
12,678,969
Loss from operations
-23,377,000
-19,997,736
-10,916,456*
-12,678,969
Changes in fair value of warrant liabilities
1,111,000
482,474
110,883,441*
-61,598,908
Interest expense
62,000
62,745
110,788*
43,292
Interest income
1,709,000
1,047,197
-533,667*
655,233
Other income, net
350,000
626,873
836,141*
765,881
Warrant issuance cost
-
-
-
4,852,292
Warrant issuance expense
-
-
1,213,073*
-
Total other income (expense)
886,000
1,128,851
-111,904,828*
58,124,438
Net gain
-22,491,000
-18,868,885
-122,821,284*
45,445,469
Unrealized gain, change in fair value of available-for-sale securities, net of tax
-
-
46,366*
-
Foreign currency translation gain (loss)
-
-
34,114*
-
Total comprehensive income (loss)
-
-
-122,740,804
-
Basic EPS
-0.28
-0.35
-4.389
0.5
Diluted EPS
-0.28
-0.35
-2.739
-0.21
Basic Average Shares
79,753,100
53,558,639
27,963,096
10,660,500
Diluted Average Shares
79,753,100
53,558,639
44,817,123
77,863,263
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$1,709,000
Other income, net
$350,000
Net gain
-$22,491,000
Total other income
(expense)
$886,000
Changes in fair value of
warrant liabilities
$1,111,000
Interest expense
$62,000
Loss from operations
-$23,377,000
Total operating
expenses
$23,377,000
Research and development
$16,172,000
General and
administrative
$7,205,000
Buy us a coffee
SAB Biotherapeutics, Inc. (SABSW)
SAB Biotherapeutics, Inc. (SABSW)